nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Nadolol—hypertension	0.106	0.302	CrCtD
Bupranolol—Timolol—hypertension	0.09	0.257	CrCtD
Bupranolol—Pindolol—hypertension	0.0783	0.223	CrCtD
Bupranolol—Penbutolol—hypertension	0.0765	0.218	CrCtD
Bupranolol—ADRB1—hypertension	0.0718	0.543	CbGaD
Bupranolol—ADRB2—hypertension	0.0604	0.457	CbGaD
Bupranolol—ADRB3—Labetalol—hypertension	0.0209	0.0821	CbGbCtD
Bupranolol—ADRB3—Nadolol—hypertension	0.0209	0.0821	CbGbCtD
Bupranolol—Timolol—Penbutolol—hypertension	0.0203	0.0899	CrCrCtD
Bupranolol—ADRB3—Pindolol—hypertension	0.0178	0.0698	CbGbCtD
Bupranolol—Pirbuterol—Nadolol—hypertension	0.0161	0.0714	CrCrCtD
Bupranolol—Carteolol—Nadolol—hypertension	0.0128	0.0567	CrCrCtD
Bupranolol—Levobunolol—Nadolol—hypertension	0.0128	0.0567	CrCrCtD
Bupranolol—Bopindolol—Carvedilol—hypertension	0.0122	0.0541	CrCrCtD
Bupranolol—Penbutolol—Nadolol—hypertension	0.0117	0.0516	CrCrCtD
Bupranolol—ADRB2—Esmolol—hypertension	0.0113	0.0443	CbGbCtD
Bupranolol—ADRB1—Esmolol—hypertension	0.0111	0.0436	CbGbCtD
Bupranolol—Levobunolol—Timolol—hypertension	0.0109	0.0482	CrCrCtD
Bupranolol—ADRB3—Timolol—hypertension	0.0102	0.0401	CbGbCtD
Bupranolol—Penbutolol—Timolol—hypertension	0.00991	0.0439	CrCrCtD
Bupranolol—ADRB3—Carvedilol—hypertension	0.00989	0.0388	CbGbCtD
Bupranolol—Levobunolol—Pindolol—hypertension	0.00948	0.042	CrCrCtD
Bupranolol—Carteolol—Pindolol—hypertension	0.00948	0.042	CrCrCtD
Bupranolol—Nadolol—Pindolol—hypertension	0.00948	0.042	CrCrCtD
Bupranolol—Levobunolol—Penbutolol—hypertension	0.00926	0.041	CrCrCtD
Bupranolol—Carteolol—Penbutolol—hypertension	0.00926	0.041	CrCrCtD
Bupranolol—Nadolol—Penbutolol—hypertension	0.00926	0.041	CrCrCtD
Bupranolol—ADRB3—Propranolol—hypertension	0.0091	0.0357	CbGbCtD
Bupranolol—ADRB2—Nadolol—hypertension	0.00855	0.0336	CbGbCtD
Bupranolol—ADRB2—Nebivolol—hypertension	0.00855	0.0336	CbGbCtD
Bupranolol—ADRB2—Labetalol—hypertension	0.00855	0.0336	CbGbCtD
Bupranolol—ADRB1—Nebivolol—hypertension	0.00842	0.033	CbGbCtD
Bupranolol—ADRB1—Labetalol—hypertension	0.00842	0.033	CbGbCtD
Bupranolol—ADRB1—Nadolol—hypertension	0.00842	0.033	CbGbCtD
Bupranolol—Salbutamol—Nadolol—hypertension	0.00819	0.0363	CrCrCtD
Bupranolol—ADRB2—Acebutolol—hypertension	0.00782	0.0307	CbGbCtD
Bupranolol—ADRB1—Acebutolol—hypertension	0.0077	0.0302	CbGbCtD
Bupranolol—ADRB2—Metoprolol—hypertension	0.00727	0.0285	CbGbCtD
Bupranolol—ADRB2—Pindolol—hypertension	0.00727	0.0285	CbGbCtD
Bupranolol—ADRB1—Pindolol—hypertension	0.00716	0.0281	CbGbCtD
Bupranolol—ADRB1—Metoprolol—hypertension	0.00716	0.0281	CbGbCtD
Bupranolol—Pindolol—Nadolol—hypertension	0.00701	0.031	CrCrCtD
Bupranolol—ADRB2—Betaxolol—hypertension	0.00648	0.0254	CbGbCtD
Bupranolol—ADRB1—Betaxolol—hypertension	0.00638	0.025	CbGbCtD
Bupranolol—Pindolol—Acebutolol—hypertension	0.00617	0.0273	CrCrCtD
Bupranolol—ADRB2—Penbutolol—hypertension	0.00592	0.0233	CbGbCtD
Bupranolol—ADRB1—Penbutolol—hypertension	0.00584	0.0229	CbGbCtD
Bupranolol—Bopindolol—Propranolol—hypertension	0.0058	0.0257	CrCrCtD
Bupranolol—Levobunolol—Propranolol—hypertension	0.0058	0.0257	CrCrCtD
Bupranolol—Carteolol—Propranolol—hypertension	0.0058	0.0257	CrCrCtD
Bupranolol—Pindolol—Metoprolol—hypertension	0.0056	0.0248	CrCrCtD
Bupranolol—Pindolol—Esmolol—hypertension	0.00531	0.0235	CrCrCtD
Bupranolol—Penbutolol—Propranolol—hypertension	0.00528	0.0234	CrCrCtD
Bupranolol—Pindolol—Betaxolol—hypertension	0.00468	0.0207	CrCrCtD
Bupranolol—ADRB2—Timolol—hypertension	0.00417	0.0164	CbGbCtD
Bupranolol—ADRB1—Timolol—hypertension	0.00411	0.0161	CbGbCtD
Bupranolol—ADRB2—Carvedilol—hypertension	0.00404	0.0159	CbGbCtD
Bupranolol—ADRB1—Carvedilol—hypertension	0.00398	0.0156	CbGbCtD
Bupranolol—ADRB2—Propranolol—hypertension	0.00372	0.0146	CbGbCtD
Bupranolol—ADRB1—Propranolol—hypertension	0.00366	0.0144	CbGbCtD
Bupranolol—Pindolol—Propranolol—hypertension	0.00317	0.0141	CrCrCtD
Bupranolol—ADRB2—Treprostinil—Nadolol—hypertension	0.000524	1	CbGdCrCtD
Bupranolol—Clenbuterol—NGF—hypertension	0.000248	0.141	CrCbGaD
Bupranolol—Gemfibrozil—PPARA—hypertension	0.000215	0.123	CrCbGaD
Bupranolol—Pirbuterol—ADRB1—hypertension	7.76e-05	0.0443	CrCbGaD
Bupranolol—Levobunolol—ADRB1—hypertension	6.92e-05	0.0395	CrCbGaD
Bupranolol—Timolol—ADRB1—hypertension	6.6e-05	0.0377	CrCbGaD
Bupranolol—Pirbuterol—ADRB2—hypertension	6.53e-05	0.0373	CrCbGaD
Bupranolol—Carteolol—ADRB1—hypertension	5.88e-05	0.0336	CrCbGaD
Bupranolol—Levobunolol—ADRB2—hypertension	5.82e-05	0.0332	CrCbGaD
Bupranolol—Timolol—ADRB2—hypertension	5.55e-05	0.0317	CrCbGaD
Bupranolol—Bopindolol—HTR1B—hypertension	5.42e-05	0.0309	CrCbGaD
Bupranolol—Terbutaline—ADRB2—hypertension	5.32e-05	0.0304	CrCbGaD
Bupranolol—Nadolol—ADRB1—hypertension	5.24e-05	0.0299	CrCbGaD
Bupranolol—Penbutolol—HTR1B—hypertension	5.17e-05	0.0295	CrCbGaD
Bupranolol—Clenbuterol—ADRB1—hypertension	5.06e-05	0.0289	CrCbGaD
Bupranolol—Carteolol—ADRB2—hypertension	4.95e-05	0.0282	CrCbGaD
Bupranolol—Clenbuterol—TNF—hypertension	4.8e-05	0.0274	CrCbGaD
Bupranolol—Bopindolol—ADRB1—hypertension	4.79e-05	0.0274	CrCbGaD
Bupranolol—Salbutamol—ADRB1—hypertension	4.7e-05	0.0268	CrCbGaD
Bupranolol—Penbutolol—ADRB1—hypertension	4.57e-05	0.0261	CrCbGaD
Bupranolol—Nadolol—ADRB2—hypertension	4.41e-05	0.0252	CrCbGaD
Bupranolol—Clenbuterol—ADRB2—hypertension	4.25e-05	0.0243	CrCbGaD
Bupranolol—Bopindolol—ADRB2—hypertension	4.03e-05	0.023	CrCbGaD
Bupranolol—Salbutamol—ADRB2—hypertension	3.95e-05	0.0226	CrCbGaD
Bupranolol—Penbutolol—ADRB2—hypertension	3.85e-05	0.022	CrCbGaD
Bupranolol—Pindolol—HTR1B—hypertension	3.73e-05	0.0213	CrCbGaD
Bupranolol—Clenbuterol—CYP1A1—hypertension	3.65e-05	0.0208	CrCbGaD
Bupranolol—Pindolol—ADRB1—hypertension	3.3e-05	0.0188	CrCbGaD
Bupranolol—Pindolol—ADRB2—hypertension	2.77e-05	0.0158	CrCbGaD
Bupranolol—ADRB2—Signaling by GPCR—CALM1—hypertension	2.61e-06	7.58e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CYBA—hypertension	2.61e-06	7.57e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FLT1—hypertension	2.61e-06	7.57e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRB1—hypertension	2.61e-06	7.57e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD3—hypertension	2.61e-06	7.57e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KDR—hypertension	2.59e-06	7.53e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CALCA—hypertension	2.58e-06	7.49e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRA2A—hypertension	2.56e-06	7.45e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLAT—hypertension	2.55e-06	7.41e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GHRL—hypertension	2.55e-06	7.41e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CALCA—hypertension	2.52e-06	7.32e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BDKRB2—hypertension	2.52e-06	7.31e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—POMC—hypertension	2.51e-06	7.3e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—F2—hypertension	2.51e-06	7.28e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PRKCB—hypertension	2.51e-06	7.28e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—F2—hypertension	2.49e-06	7.24e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKCB—hypertension	2.49e-06	7.24e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FN1—hypertension	2.49e-06	7.24e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRBK1—hypertension	2.49e-06	7.23e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CNR1—hypertension	2.47e-06	7.18e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BDKRB2—hypertension	2.46e-06	7.15e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—POMC—hypertension	2.46e-06	7.14e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—F2—hypertension	2.45e-06	7.12e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PRKCB—hypertension	2.45e-06	7.12e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CALM2—hypertension	2.44e-06	7.1e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOTCH1—hypertension	2.44e-06	7.09e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRBK1—hypertension	2.43e-06	7.07e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CNR1—hypertension	2.42e-06	7.02e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AKT2—hypertension	2.42e-06	7.02e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD2—hypertension	2.41e-06	7e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR7—hypertension	2.41e-06	7e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CALM2—hypertension	2.39e-06	6.95e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GCG—hypertension	2.39e-06	6.93e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTPN1—hypertension	2.39e-06	6.93e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AKT2—hypertension	2.36e-06	6.87e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD2—hypertension	2.36e-06	6.85e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR7—hypertension	2.36e-06	6.85e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KL—hypertension	2.34e-06	6.8e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOTCH2—hypertension	2.34e-06	6.8e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GCG—hypertension	2.33e-06	6.78e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTPN1—hypertension	2.33e-06	6.78e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NGFR—hypertension	2.3e-06	6.67e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ITGAV—hypertension	2.3e-06	6.67e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KNG1—hypertension	2.29e-06	6.65e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KL—hypertension	2.29e-06	6.65e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOTCH2—hypertension	2.29e-06	6.65e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—POMC—hypertension	2.28e-06	6.63e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRL—hypertension	2.28e-06	6.61e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGTR1—hypertension	2.28e-06	6.61e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—POMC—hypertension	2.27e-06	6.6e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—INS—hypertension	2.26e-06	6.56e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NGFR—hypertension	2.25e-06	6.53e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ITGAV—hypertension	2.25e-06	6.53e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STK11—hypertension	2.24e-06	6.52e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HDAC1—hypertension	2.24e-06	6.52e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KNG1—hypertension	2.24e-06	6.51e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL2—hypertension	2.23e-06	6.49e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—POMC—hypertension	2.23e-06	6.49e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGTR1—hypertension	2.23e-06	6.47e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRL—hypertension	2.23e-06	6.47e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL10—hypertension	2.22e-06	6.46e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL2—hypertension	2.22e-06	6.46e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLG—hypertension	2.22e-06	6.44e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—RHOA—hypertension	2.21e-06	6.43e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STK11—hypertension	2.19e-06	6.38e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HDAC1—hypertension	2.19e-06	6.38e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AKT2—hypertension	2.19e-06	6.37e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3R1—hypertension	2.19e-06	6.37e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF1—hypertension	2.18e-06	6.35e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL2—hypertension	2.18e-06	6.35e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKT2—hypertension	2.18e-06	6.34e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL10—hypertension	2.18e-06	6.32e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EGFR—hypertension	2.17e-06	6.32e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLG—hypertension	2.17e-06	6.3e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RHOA—hypertension	2.17e-06	6.29e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRB2—hypertension	2.16e-06	6.27e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AKT2—hypertension	2.15e-06	6.23e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3R1—hypertension	2.14e-06	6.23e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCE—hypertension	2.13e-06	6.19e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFA—hypertension	2.11e-06	6.12e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VAV3—hypertension	2.11e-06	6.12e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCE—hypertension	2.09e-06	6.06e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFBR2—hypertension	2.08e-06	6.03e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SERPINE1—hypertension	2.07e-06	6.03e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFA—hypertension	2.06e-06	5.98e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VAV3—hypertension	2.06e-06	5.98e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GNB3—hypertension	2.06e-06	5.97e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFBR2—hypertension	2.03e-06	5.9e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AVP—hypertension	2.03e-06	5.89e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GNB3—hypertension	2.01e-06	5.84e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RHOA—hypertension	2.01e-06	5.84e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGF2—hypertension	2.01e-06	5.84e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GNAS—hypertension	2e-06	5.82e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RHOA—hypertension	2e-06	5.82e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3R1—hypertension	1.99e-06	5.78e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AVP—hypertension	1.98e-06	5.77e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3R1—hypertension	1.98e-06	5.76e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOS3—hypertension	1.98e-06	5.76e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RHOA—hypertension	1.97e-06	5.72e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOB—hypertension	1.96e-06	5.7e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GNAS—hypertension	1.96e-06	5.69e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTK2—hypertension	1.95e-06	5.67e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3R1—hypertension	1.95e-06	5.66e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—hypertension	1.94e-06	5.65e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDN1—hypertension	1.93e-06	5.61e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOB—hypertension	1.92e-06	5.57e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL5—hypertension	1.91e-06	5.56e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTK2—hypertension	1.91e-06	5.55e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—hypertension	1.9e-06	5.53e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDN1—hypertension	1.89e-06	5.48e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL5—hypertension	1.87e-06	5.44e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LPL—hypertension	1.87e-06	5.44e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RELA—hypertension	1.86e-06	5.42e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—H2AFX—hypertension	1.86e-06	5.4e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFRB—hypertension	1.86e-06	5.39e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RPS6KB1—hypertension	1.86e-06	5.39e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADCY5—hypertension	1.83e-06	5.33e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LPL—hypertension	1.83e-06	5.32e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MTOR—hypertension	1.83e-06	5.31e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCG—hypertension	1.82e-06	5.29e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—H2AFX—hypertension	1.82e-06	5.28e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RPS6KB1—hypertension	1.82e-06	5.27e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFRB—hypertension	1.82e-06	5.27e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCA—hypertension	1.81e-06	5.25e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ITGB3—hypertension	1.81e-06	5.25e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—YWHAZ—hypertension	1.79e-06	5.21e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADCY5—hypertension	1.79e-06	5.21e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCG—hypertension	1.78e-06	5.17e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NGF—hypertension	1.77e-06	5.15e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SPP1—hypertension	1.77e-06	5.15e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ITGB3—hypertension	1.77e-06	5.14e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCA—hypertension	1.77e-06	5.14e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—hypertension	1.77e-06	5.13e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—hypertension	1.76e-06	5.11e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—YWHAZ—hypertension	1.75e-06	5.1e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NGF—hypertension	1.73e-06	5.04e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SPP1—hypertension	1.73e-06	5.04e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—hypertension	1.73e-06	5.02e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR5—hypertension	1.72e-06	5.01e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCD—hypertension	1.72e-06	5.01e-05	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AKT1—hypertension	1.7e-06	4.93e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—hypertension	1.69e-06	4.9e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR5—hypertension	1.69e-06	4.9e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCD—hypertension	1.69e-06	4.9e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—C3—hypertension	1.69e-06	4.9e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—hypertension	1.67e-06	4.85e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—hypertension	1.65e-06	4.8e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—C3—hypertension	1.65e-06	4.79e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDGFB—hypertension	1.64e-06	4.77e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGFR1—hypertension	1.63e-06	4.74e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HIF1A—hypertension	1.61e-06	4.67e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDGFB—hypertension	1.61e-06	4.66e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGT—hypertension	1.6e-06	4.65e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGFR1—hypertension	1.6e-06	4.64e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—hypertension	1.59e-06	4.62e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CDKN1A—hypertension	1.58e-06	4.6e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTEN—hypertension	1.58e-06	4.59e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CALM1—hypertension	1.57e-06	4.58e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HIF1A—hypertension	1.57e-06	4.57e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOE—hypertension	1.57e-06	4.56e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LEP—hypertension	1.57e-06	4.56e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGT—hypertension	1.57e-06	4.55e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CAV1—hypertension	1.55e-06	4.52e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOA1—hypertension	1.55e-06	4.51e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK8—hypertension	1.55e-06	4.49e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AKT1—hypertension	1.54e-06	4.48e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CALM1—hypertension	1.54e-06	4.48e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KDR—hypertension	1.54e-06	4.47e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LEP—hypertension	1.54e-06	4.46e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOE—hypertension	1.54e-06	4.46e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CAV1—hypertension	1.52e-06	4.42e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOA1—hypertension	1.52e-06	4.41e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EP300—hypertension	1.51e-06	4.38e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KDR—hypertension	1.5e-06	4.37e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—F2—hypertension	1.48e-06	4.3e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCB—hypertension	1.48e-06	4.3e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FN1—hypertension	1.48e-06	4.3e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SRC—hypertension	1.47e-06	4.26e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOTCH1—hypertension	1.45e-06	4.21e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCB—hypertension	1.45e-06	4.21e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—F2—hypertension	1.45e-06	4.21e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FN1—hypertension	1.45e-06	4.21e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—hypertension	1.43e-06	4.15e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOTCH1—hypertension	1.42e-06	4.12e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—POMC—hypertension	1.35e-06	3.92e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—INS—hypertension	1.34e-06	3.9e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL2—hypertension	1.32e-06	3.83e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—POMC—hypertension	1.32e-06	3.83e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MYC—hypertension	1.31e-06	3.81e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—INS—hypertension	1.31e-06	3.81e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFB1—hypertension	1.31e-06	3.81e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF1—hypertension	1.3e-06	3.77e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT2—hypertension	1.3e-06	3.77e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EGFR—hypertension	1.29e-06	3.75e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL2—hypertension	1.29e-06	3.75e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EGFR—hypertension	1.28e-06	3.73e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF1—hypertension	1.27e-06	3.69e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT2—hypertension	1.27e-06	3.68e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EGFR—hypertension	1.26e-06	3.67e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SERPINE1—hypertension	1.23e-06	3.58e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SERPINE1—hypertension	1.2e-06	3.5e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF2—hypertension	1.19e-06	3.46e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RHOA—hypertension	1.19e-06	3.45e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOS3—hypertension	1.18e-06	3.42e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3R1—hypertension	1.18e-06	3.42e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF2—hypertension	1.17e-06	3.39e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RHOA—hypertension	1.16e-06	3.38e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3R1—hypertension	1.15e-06	3.34e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOS3—hypertension	1.15e-06	3.34e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RELA—hypertension	1.11e-06	3.22e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MTOR—hypertension	1.09e-06	3.15e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RELA—hypertension	1.08e-06	3.15e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TP53—hypertension	1.08e-06	3.13e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MTOR—hypertension	1.06e-06	3.08e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—hypertension	1.04e-06	3.03e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—hypertension	1.02e-06	2.96e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AKT1—hypertension	1.01e-06	2.93e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—hypertension	9.92e-07	2.88e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—hypertension	9.87e-07	2.87e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AKT1—hypertension	9.86e-07	2.86e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—hypertension	9.7e-07	2.82e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—hypertension	9.43e-07	2.74e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CDKN1A—hypertension	9.4e-07	2.73e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTEN—hypertension	9.38e-07	2.72e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—hypertension	9.23e-07	2.68e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CDKN1A—hypertension	9.19e-07	2.67e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK8—hypertension	9.17e-07	2.67e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTEN—hypertension	9.17e-07	2.67e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AKT1—hypertension	9.15e-07	2.66e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKT1—hypertension	9.11e-07	2.65e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK8—hypertension	8.97e-07	2.61e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AKT1—hypertension	8.95e-07	2.6e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EP300—hypertension	8.94e-07	2.6e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EP300—hypertension	8.75e-07	2.54e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SRC—hypertension	8.7e-07	2.53e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SRC—hypertension	8.51e-07	2.47e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—hypertension	8.47e-07	2.46e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—hypertension	8.29e-07	2.41e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MYC—hypertension	7.79e-07	2.26e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFB1—hypertension	7.77e-07	2.26e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MYC—hypertension	7.62e-07	2.21e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EGFR—hypertension	7.62e-07	2.21e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFB1—hypertension	7.61e-07	2.21e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EGFR—hypertension	7.46e-07	2.17e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TP53—hypertension	6.4e-07	1.86e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TP53—hypertension	6.26e-07	1.82e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—hypertension	5.86e-07	1.7e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—hypertension	5.73e-07	1.67e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT1—hypertension	5.4e-07	1.57e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT1—hypertension	5.29e-07	1.54e-05	CbGpPWpGaD
